New Provider Hot Tip

New Pharmacy Hot Tip has been posted to MO HealthNet

November 13, 2023   Hot Tips RSV Prophylaxis Update November 8, 2023 Due to current supply constraints for the new RSV prophylaxis agent Beyfortus (nirsevimab), the MO HealthNet Division (MHD) will allow up to five doses of Synagis (palivizumab) for the 2023 – 2024 RSV season. Participants who meet the clinical edit requirements, including age restrictions, may receive approval for up to five doses to start the 2023 - 2024 RSV season, depending on the requested date for the initial prior authorization. MHD will automatically extend prior authorization requests for Synagis that were previously approved from 10/31/2023 – 11/7/2023 for only two doses to up to five doses to cover the full season. MHD recommends pharmacies coordinate with providers to ensure a scheduled appointment exists with their patient to administer Synagis before sending doses to reduce abandoned medication. MHD will evaluate claims to ensure there is no excessive waste. Providers with questions may call MO HealthNet at 800-392-8030. Contact Us For questions about pharmacy or MORx, please email: MHD.PharmacyAdmin@dss.mo.gov. For questions about psychology, exceptions, or medical pre-certifications, please email: Clinical.Services@dss.mo.gov For all other questions or comments, please email: Ask.MHD@dss.mo.gov Our Mission: Empower Missourians to live safe, healthy, and productive lives.     Note: replies to this email address will not be monitored.

---

This newsletter is provided to you by the Missouri Department of Social Services

---

This email was sent to ignoble.experiment@arconati.us using GovDelivery Communications Cloud on behalf of: Missouri Department of Social Services · Broadway State Office Building PO Box 1527 · Jefferson City, MO 65102